ACT-HIB
ACT-HIB
Approved
DIN Number
01959034
Drug Class
Human
Market Date
Dec 31, 1992
Company
HC
Sanofi Pasteur Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number01959034
AIG Number0240222003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07AG01 HEMOPHILUS INFLUENZAE B, PURIFIED ANTIG. CONJUGATED
Product Specifications
Dosage FormPowder For Solution
,
Kit
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
HAEMOPHILUS INFLUENZAE TYPE B-PRPActive
Strength: 10 MCG / 0.5 ML
Monograph: HAEMOPHILUS INFLUENZAE TYPE B-PRP
TETANUS PROTEINActive
Strength: 30 MCG / 0.5 ML
Monograph: TETANUS PROTEIN